Veröffentlicht: 23 April 2024
Pratteln
100%
Festanstellung
Santhera Pharmaceuticals (Schweiz) AG
Jobs online gefunden
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular and pulmonary diseases with high unmet medical need. For further information, please visit the Company's website www.santhera.com Come and join our team to contribute to providing treatment options for patients with rare diseases that have a severe impact on the lives of affected children and adults. You can make a difference as Medical Director
Starting date: April 2024
Location: HQ Pratteln (CH), hybrid Who you are
We are seeking a highly skilled and motivated individual to join us as the Medical Director for Clinical Development. This pivotal role offers a unique opportunity to lead clinical development programs across multiple therapeutic areas, shaping the future of healthcare on a global scale. Scope of Work
To provide medical leadership and clinical development expertise (including clinical trials design, trials protocol development and program life cycle strategy and planning across all phases of development, support data interpretation and input into medical regulatory strategy, business development) on Santhera development programs, in interactions with clinical experts and regulatory authorities to support clinical development activities. This role will further help to build medical and clinical science expertise and resources across current and future program, portfolios and pipeline opportunities in line with Santhera growth plans. It represents the medical and clinical science function at the Santhera Clinical Program Committee. The role reports to the Head of Development working in close collaboration with internal Santhera development, and global Project Team business development, commercial, medical affairs and externally with Health Authorities, Ethics committees, external consultants, key opinion leaders (KOLs), funding committees, investigators and patient advocacy groups. Key Responsibilities: